公开(公告)号：EP4321535A1

公开(公告)日：2024-02-14

申请号：EP22784923.9

申请日：2022-04-05

申请人： Genome and Company

发明人： JEON, Bu Nam ,  CHUNG, Joo Yeon ,  MOON, Soo Jung ,  KIM, Hyunuk ,  CHA, Mi Young ,  CHUNG, Junho ,  JIN, Junyeong ,  KIM, Soohyun ,  CHAE, Jisu

IPC分类号： C07K16/28 ,  A61K47/68 ,  A61P35/00 ,  A61K39/00

摘要： The present invention relates to an anti-CNTN4 antibody or an antigen-binding fragment thereof, a pharmaceutical composition containing the same, and a use thereof for activating T cells upregulating cell-mediated immune responses, for example, for treating cancer.

公开(公告)号：EP4342914A1

公开(公告)日：2024-03-27

申请号：EP21940919.0

申请日：2021-06-01

申请人： Genome and Company

发明人： CHA, Mi Young ,  YU, Hyunkyung ,  JEON, Bu Nam ,  KIM, Hyunuk

IPC分类号： C07K16/28 ,  A61P35/00 ,  A61K39/00

摘要： The present invention relates to an anti-BCAM antibody or an antigen-binding fragment thereof, and uses thereof. In addition, the anti-BCAM antibody or antigen-binding fragment thereof according to the present invention can be used for preventing or treating a state associated with cells expressing BCAM, for example, cancer..

公开(公告)号：EP4332116A1

公开(公告)日：2024-03-06

申请号：EP21939415.2

申请日：2021-04-29

申请人： Genome and Company

发明人： JEON, Bu Nam ,  HOUH, Youn Kyung ,  KIM, Yun Yeon ,  CHA, Mi Young

IPC分类号： C07K16/28 ,  A61K47/68 ,  A61P35/00 ,  G01N33/577 ,  A61K39/00

摘要： The present invention relates to anti-CNTN4 antibodies or antigen-binding fragments thereof, and use thereof for activating T cells that upregulate a cell-mediated immune response, for example, use thereof for the treatment of cancer.